Novartis AG (NVS)
103.85
+0.76
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
104.38
+0.53
(+0.51%)
Pre-Market: 07:53
Novartis Total Liabilities (Quarterly): 60.08B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 60.08B |
| June 30, 2024 | 55.60B |
| March 31, 2024 | 54.58B |
| December 31, 2023 | 53.20B |
| September 30, 2023 | 74.45B |
| June 30, 2023 | 59.05B |
| March 31, 2023 | 60.10B |
| December 31, 2022 | 58.03B |
| September 30, 2022 | 57.57B |
| June 30, 2022 | 59.90B |
| March 31, 2022 | 63.51B |
| December 31, 2021 | 63.97B |
| September 30, 2021 | 64.27B |
| June 30, 2021 | 69.89B |
| March 31, 2021 | 71.16B |
| December 31, 2020 | 71.11B |
| September 30, 2020 | 75.12B |
| June 30, 2020 | 69.88B |
| March 31, 2020 | 72.12B |
| December 31, 2019 | 62.82B |
| September 30, 2019 | 63.37B |
| June 30, 2019 | 64.79B |
| March 31, 2019 | 90.64B |
| December 31, 2018 | 66.87B |
| September 30, 2018 | 64.98B |
| Date | Value |
|---|---|
| June 30, 2018 | 65.16B |
| March 31, 2018 | 64.31B |
| December 31, 2017 | 58.85B |
| September 30, 2017 | 62.60B |
| June 30, 2017 | 63.77B |
| March 31, 2017 | 64.34B |
| December 31, 2016 | 55.23B |
| September 30, 2016 | 58.94B |
| June 30, 2016 | 58.90B |
| March 31, 2016 | 60.56B |
| December 31, 2015 | 54.43B |
| September 30, 2015 | 56.14B |
| June 30, 2015 | 56.58B |
| March 31, 2015 | 58.49B |
| December 31, 2014 | 54.54B |
| September 30, 2014 | 53.95B |
| June 30, 2014 | 55.25B |
| March 31, 2014 | 55.00B |
| December 31, 2013 | 51.78B |
| September 30, 2013 | 52.42B |
| June 30, 2013 | 51.44B |
| March 31, 2013 | 53.86B |
| December 31, 2012 | 54.93B |
| September 30, 2012 | 54.01B |
| June 30, 2012 | 54.25B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
53.20B
Minimum
Dec 2023
75.12B
Maximum
Sep 2020
63.82B
Average
63.17B
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 64.12B |
| Johnson & Johnson | 108.13B |
| Eli Lilly and Co | 61.29B |
| Novo Nordisk AS | 41.48B |
| Monte Rosa Therapeutics Inc | 109.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.52B |
| Shareholders Equity (Quarterly) | 43.32B |
| Debt to Equity Ratio | 0.6999 |
| Current Ratio | 1.111 |
| Net Debt Paydown Yield | -0.33% |